PANGRAF (TACROLIMUS)

Pangraf (Tacrolimus) 1 MG Capsule is an immuno-suppressant which is used in kidney, liver, and heart transplant patients. It should be used under the supervision of a qualified physician. Close monitoring of blood pressure is necessary while receiving this medicine.

Pangraf (Tacrolimus) Capsules suppliers in India. Allevaire India Network New Delhi, INDIA.

Alleviare Life sciences Pvt. Ltd. is a consulting pharmaceutical company specialized in providing medicines under Named Patient Program/Manage Access Program. Named Patient Program/ Manage Access Program is a program designed by the government of India and governments of many countries worldwide for patients who have exhausted the treatment options available in their respective countries and are in need of latest medicines that are available in countries of Europe and USA.

The order for Pangraf (Tacrolimus) Capsules will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

PROGRAF® is indicated for the prophylaxis of organ rejection, in patients receiving allogeneic kidney transplant, liver transplants and heart transplant, in combination with other immunosuppressants.

Uses of Pangraf (Tacrolimus) Capsules:

Pangraf (Tacrolimus) is used with other medications to prevent rejection of a kidney, heart, or liver transplant. This medication belongs to a class of drugs known as immunosuppressants. It works by weakening your body’s defense system (immune system) to help your body accept the new organ as if it were your own.

Medicine Name: Pangraf Capsules
Generic Name: Tacrolimus
Approval Date: 04/08/1994.
Company Name: Panacea

Available as (Form & Strength): 0.5 mg, 1 mg and 5 mg and injection 5 mg/mL